Moderna, Inc. (NASDAQ: MRNA) shares are swinging in volatile early trading on Friday, February 27, 2026, as investors digest ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Moderna (MRNA) stock has shed roughly 90% of its value since its 2021 peak.

This prompts a reassessment of the stock’s value to determine if this represents a genuine opportunity or a potential trap.

Moderna (MRNA) stock closed higher on Wednesday after the FDA reversed its earlier refusal-to-file decision on the company’s ...

If you are wondering whether Moderna's current share price reflects its true potential, or if the market is still anchored to ...

Moderna Inc (NASDAQ:MRNA) shares are trading lower on Friday afternoon, giving back a portion of the gains seen on Thursday. Here’s what investors need to know. What To Know: The stock spiked on ...

What a fantastic six months it’s been for Moderna. Shares of the company have skyrocketed 99.8%, hitting $50.65. This was ...

Moderna Inc MRNA shares are trading higher on Monday. Piper Sandler boosted its price target on the stock to $69 from $63 ...

The stock’s movement comes after the U.S. Food and Drug Administration (FDA) notified Moderna that its biologics license ...

U.S. FDA issues a Refusal to File for Moderna's mRNA flu vaccine BLA, citing concerns with the trial comparator rather than safety or efficacy. Moderna, ticker NasdaqGS:MRNA, says the trial design and ...